Advanced Accounting 12th Edition by Joe Ben Hoyle,Thomas Schaefer , Timothy Doupnik

تمرين 39

On March 7, 2012, Celgene Corporation acquired all of the outstanding stock of Avila Therapeutics, Inc. in exchange for $352.2 million in cash plus contingent consideration. Referring to Celgene's 2012 financial statements answer the following questions regarding the Avila Therapeutics acquisition.
What allocations did Celgene make to the assets acquired and liabilities assumed in the acquisition Provide a calculation showing how Celgene determined the amount allocated to goodwill.